Molecular basis of bacterial pathogenesis, virulence factors and antibiotic resistance
This organism emerged worldwide as causative agents of enteric infections with high mortality and morbidity, is resistant to multiple antibiotics and primarily affects patients with a disturbed microbiome. C. difficile infections can be treated by fecal microbiota transplantation, which is also explored for other diseases.
A better understanding of the virulence characteristics of C. difficile and other pathogenic bacteria, as well the relation between the microbiota and health or disease, should result in the development of better diagnostics and therapeutic interventions, including new antiobiotics and the application of live biotherapeutic products is considered key for human and animal health.
Research lines
The Bacteriology Research Programme of Medical Microbiology focusses on the following research lines:
Principal investigators
Principal investigators:
Dr. J. Corver, Em. Prof. Dr. E.J. Kuijper, Dr. W.K. Smits
The microbiome in health and disease (Center for microbiome analyses and therapeutics; CMAT)
Principal investigators:
Em. Prof. Dr. E.J. Kuijper, Dr. W.K. Smits, Dr. E.M. Terveer